IRHYTHM TECHNOLOGIES INC. - COMMON STOCK

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

07 Jul 2025 05:30:00 By Nasdaq GlobeNewswire

New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease

23 Jun 2025 05:30:00 By Nasdaq GlobeNewswire

iRhythm Technologies to Participate in Upcoming Investor Conferences

21 May 2025 13:45:00 By Nasdaq GlobeNewswire

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

01 May 2025 13:10:00 By Nasdaq GlobeNewswire

iRhythm Technologies Announces First Quarter 2025 Financial Results

01 May 2025 13:05:00 By Nasdaq GlobeNewswire

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

29 Apr 2025 15:05:00 By Nasdaq GlobeNewswire

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

28 Apr 2025 05:05:00 By Nasdaq GlobeNewswire

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

17 Apr 2025 13:30:00 By Nasdaq GlobeNewswire

iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

16 Apr 2025 05:35:00 By Nasdaq GlobeNewswire

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

31 Mar 2025 05:05:00 By Nasdaq GlobeNewswire

iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

20 Feb 2025 13:05:00 By Nasdaq GlobeNewswire

iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

06 Feb 2025 13:05:00 By Nasdaq GlobeNewswire

iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference

13 Jan 2025 05:30:00 By Nasdaq GlobeNewswire

iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

30 Dec 2024 13:30:00 By Nasdaq GlobeNewswire

iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference

20 Nov 2024 13:30:00 By Nasdaq GlobeNewswire

iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring

18 Nov 2024 05:15:00 By Nasdaq GlobeNewswire

iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference

05 Nov 2024 13:30:00 By Nasdaq GlobeNewswire

iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device

30 Oct 2024 14:15:08 By Nasdaq GlobeNewswire

iRhythm Technologies Announces Third Quarter 2024 Financial Results

30 Oct 2024 13:08:07 By Nasdaq GlobeNewswire

Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy

28 Oct 2024 05:02:00 By Nasdaq GlobeNewswire